Assessment of liver metastases from colorectal adenocarcinoma following chemotherapy: SPIO-MRI versus FDG-PET/CT;Valutazione con SPIO-RM e TC-PET-FDG di metastasi epatiche di adenocarcinoma colorettale dopo chemioterapia

Radiologia Medica

Volumn 115, Issue 7, 2010, Pages 1087-1100

  Bacigalupo, L ^a   Aufort, S ^b   Eberle M C ^c   Assenat, E ^c   Ychou, M ^c   Gallix, B ^b  

^a GALLIERA HOSPITAL   (Italy)

^b MONTPELLIER UNIVERSITY HOSPITAL   (France)

^c CENTRE VAL D AURELLE   (France)

Author keywords

Colorectal carcinoma; FDG PET CT; Liver; Metastasis; MRI

Indexed keywords

CONTRAST MEDIUM; DIAGNOSTIC AGENT; FLUORODEOXYGLUCOSE F 18; MAGNETITE; RADIOPHARMACEUTICAL AGENT;

ADENOCARCINOMA; ADULT; AGED; ARTICLE; COLORECTAL TUMOR; COMPARATIVE STUDY; COMPUTER ASSISTED TOMOGRAPHY; CONTACT DERMATITIS; FEMALE; HUMAN; LIVER TUMOR; MALE; METASTASIS; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; POSITRON EMISSION TOMOGRAPHY;

ADENOCARCINOMA; ADULT; AGED; COLORECTAL NEOPLASMS; CONTRAST MEDIA; DERMATITIS, CONTACT; FEMALE; FERROSOFERRIC OXIDE; FLUORODEOXYGLUCOSE F18; HUMANS; LIVER NEOPLASMS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 78649326186     PISSN: 00338362     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11547-010-0560-x     Document Type: Article

References (35)

1. J. Weitz M. Koch J. Debus, et al. 2005 Colorectal cancer Lancet 365 153 165 10.1016/S0140-6736(05)17706-X 15639298 (Pubitemid 40091806)
2. C. Penna B. Nordlinger 2002 Colorectal metastasis (liver and lung) Surg Clin N Am 82 1075 1090 10.1016/S0039-6109(02)00051-8 12507210 (Pubitemid 35463085)
3. R. Stangl A. Altendorf-Hofmann R.M. Charnley J. Scheele 1994 Factors influencing the natural history of colorectal liver metastases Lancet 343 1405 1410 1:STN:280:DyaK2c3lsVGhug%3D%3D 10.1016/S0140-6736(94)92529-1 7515134 (Pubitemid 24167517)
4. N. Tomizawa S. Ohwada T. Ogawa, et al. 2006 Factors affecting the prognosis of anatomical liver resection for liver metastases from colorectal cancer Hepatogastroenterology 53 89 93 16506383
5. J.N. Vauthey D. Zorzi T.M. Pawlik 2005 Making Unresectable Hepatic Colorectal Metastases Resectable-Does It Work? Semin Oncol 32 S118 S122 10.1053/j.seminoncol.2005.04.030 16399448 (Pubitemid 43080932)
6. K. Kinkel Y. Lu M. Both, et al. 2002 Detection of hepatic metastases from cancers of the gastrointestinal tract by using noninvasive imaging methods (US, CT, MR imaging, PET): a metaanalysis Radiology 224 748 756 10.1148/radiol. 2243011362 12202709
7. W. Schima C. Kulinna H. Langenberger A. Ba-Ssalamah 2005 Liver metastases of colorectal cancer: US, CT or MR? Cancer Imaging 23 S149 S156 10.1102/1470-7330.2005.0035
8. R.C. Semelka W.G. Cance H.B. Marcos M.A. Mauro 1999 Liver metastases: comparison of current MR techniques and spiral CT during arterial portography for detection in 20 surgically staged cases Radiology 213 86 91 1:STN:280:DC%2BD3c%2FgvVWmuw%3D%3D 10540645
9. J. Ward P.J. Robinson J.A. Guthrie, et al. 2005 Liver Metastases in Candidates for Hepatic Resection: Comparison of Helical CT and Gadolinium- and SPIO enhanced MR Imaging Radiology 237 170 180 10.1148/radiol.2371041444 16126930 (Pubitemid 41346161)
10. Y.K. Kim S.W. Ko S.B. Hwang, et al. 2006 Detection and characterization of liver metastases: 16-slice multidetector computed tomography versus superparamagnetic iron oxide-enhanced magnetic resonance imaging Eur Radiol 16 1337 1345 10.1007/s00330-005-0140-y 16453115 (Pubitemid 43834721)
11. M.J. Kim J.H. Kim J.S. Lim, et al. 2004 Detection and characterization of focal hepatic lesions: mangafodipir vs. superparamagnetic iron oxide-enhanced magnetic resonance imaging J Magn Reson Imaging 20 612 621 10.1002/jmri.20174 15390224 (Pubitemid 39313737)
12. B. Wiering P.F. Krabbe G.J. Jager, et al. 2005 The impact of fluor-18-deoxyglucose-positron emission tomography in the management of colorectal liver metastases Cancer 104 2658 2670 10.1002/cncr.21569 16315241 (Pubitemid 41798276)
13. S. Bipat M.S. van Leeuwen E.F. Comans, et al. 2005 Colorectal Liver Metastases: CT, MR Imaging, and PET for Diagnosis-Meta-analysis Radiology 237 123 131 10.1148/radiol.2371042060 16100087 (Pubitemid 41346155)
14. D.V. Sahani S.P. Kalva A.J. Fischman, et al. 2005 Detection of liver metastases from adenocarcinoma of the colon and pancreas: comparison of mangafodipir trisodium-enhanced liver MRI and whole-body FDG PET AJR Am J Roentgenol 185 239 246 15972430
15. M. Strotzer J. Gmeinwieser J. Schmidt, et al. 1997 Diagnosis of liver metastases from colorectal adenocarcinoma. Comparison of spiral-CTAP combined with intravenous contrast-enhanced spiral-CT and SPIO-enhanced MR combined with plain MR imaging Acta Radiol 38 986 992 1:STN:280:DyaK1c%2Fls1KgtA%3D%3D 9394654
16. Y.K. Kim J.M. Lee C.S. Kim, et al. 2005 Detection of liver metastases: gadobenate dimeglumine-enhanced three-dimensional dynamic phases and one-hour delayed phase MR imaging versus superparamagnetic iron oxide-enhanced MR imaging Eur Radiol 15 220 228 10.1007/s00330-004-2570-3 15624108
17. T.J. Vogl W. Schwarz S. Blume, et al. 2003 Preoperative evaluation of malignant liver tumors: comparison of unenhanced and SPIO (Resovist)-enhanced MR imaging with biphasic CTAP and intraoperative US Eur Radiol 13 262 272 12598989
18. R. Conlon M. Jacobs D. Dasgupta J.P. Lodge 2003 The value of intraoperative ultrasound during hepatic resection compared with improved preoperative magnetic resonance imaging Eur J Ultrasound 16 211 216 10.1016/S0929-8266(02)00075-7 12573790 (Pubitemid 36173577)
19. C. Del Frate M. Bazzocchi K.J. Mortele, et al. 2002 Detection of liver metastases: comparison of gadobenate dimeglumine-enhanced and ferumoxides-enhanced MR imaging examinations Radiology 225 766 772 10.1148/radiol.2253011854 12461259
20. T. Furuhata K. Okita T. Tsuruma, et al. 2003 Efficacy of SPIO-MR imaging in the diagnosis of liver metastases from colorectal carcinomas Dig Surg 20 321 325 10.1159/000071758 12806198 (Pubitemid 36819026)
21. M.J. Kim J.H. Kim J.Y. Choi, et al. 2006 Optimal TE for SPIO-enhanced gradient-recalled echo MRI for the detection of focal hepatic lesions AJR Am J Roentgenol 187 255 266 10.2214/AJR.05.0706
22. O. Mawlawi J.J. Erasmus R.F. Munden, et al. 2006 Quantifying the effect of IV contrast media on integrated PET/CT: clinical evaluation AJR Am J Roentgenol 186 308 319 10.2214/AJR.04.1740 16423932 (Pubitemid 46100297)
23. E.D. Rappeport A. Loft A.K. Berthelsen, et al. 2007 Contrast-enhanced FDGPET/ CT vs. SPIO-enhanced MRI vs. FDG-PET vs. CT in patients with liver metastases from colorectal cancer: a prospective study with intraoperative confirmation Acta Radiol 48 369 378 1:STN:280:DC%2BD2szlt1Grug%3D%3D 10.1080/02841850701294560 17453514 (Pubitemid 46633866)
24. A. Orlacchio O. Schillaci N. Fusco, et al. 2009 Role of PET/CT in the detection of liver metastases from colorectal cancer Radiol Med 114 571 585 1:STN:280:DC%2BD1MrmsVOgtA%3D%3D 10.1007/s11547-009-0393-7 19444590
25. H. Onishi T. Murakami T. Kim, et al. 2006 Hepatic metastases: detection with multi-detector row CT, SPIO-enhanced MR imaging, and both techniques combined Radiology 239 131 138 10.1148/radiol.2383041825 16484347
26. E. Leen P. Ceccotti S.J. Moug, et al. 2006 Potential value of contrast-enhanced intraoperative ultrasonography during partial hepatectomy for metastases: an essential investigation before resection? Ann Surg 243 236 240 10.1097/01.sla.0000197708.77063.07 16432357 (Pubitemid 43185443)
27. J. Ward J.A. Guthrie D. Wilson, et al. 2003 Colorectal hepatic metastases: detection with SPIO-enhanced breath-hold MR imaging-Comparison of optimized sequences Radiology 228 709 718 10.1148/radiol.2283020376 12888620 (Pubitemid 37025481)
28. S.M. Erturk T. Ichikawa H. Fujii, et al. 2006 PET imaging for evaluation of metastatic colorectal cancer of the liver Eur J Radiol 58 229 235 10.1016/j.ejrad.2005.11.042 16457980
29. H.J. Kim K.W. Kim J.H. Byun, et al. 2006 Comparison of mangafodipir trisodium- and ferucarbotran-enhanced MRI for detection and characterization of hepatic metastases in colorectal cancer patients AJR Am J Roentgenol 186 1059 1066 10.2214/AJR.04.1941 16554579 (Pubitemid 46100208)
30. T. Akhurst T.J. Kates M. Mazumdar, et al. 2005 Recent chemotherapy reduces the sensitivity of [18F] fluorodeoxyglucose positron emission tomography in the detection of colorectal metastases J Clin Oncol 23 8713 8716 10.1200/JCO.2005.04.4222 16314631 (Pubitemid 46211515)
31. E. Goshen T. Davidson S.T. Zwas D. Aderka 2006 PET/CT in the evaluation of response to treatment of liver metastases from colorectal cancer with bevacizumab and irinotecan Technol Cancer Res Treat 5 37 43 1:STN:280: DC%2BD28%2FjtFemsQ%3D%3D 16417400
32. B. Wiering P.F. Krabbe H.M. Dekker, et al. 2007 The role of FDG-PET in the selection of patients with colorectal liver metastases Ann Surg Oncol 14 771 779 1:STN:280:DC%2BD2s%2Fks1SgsQ%3D%3D 10.1245/s10434-006-9013-0 17086488 (Pubitemid 46175326)
33. A. Patrikeos W. Breidahl P. Robins 2005 F-18 FDG uptake associated with elastofibroma dorsi Clin Nucl Med 30 617 618 10.1097/01.rlu.0000174235.00577.fc 16100483 (Pubitemid 41216155)
34. J.C. Pierce 3rd R. Henderson 2004 Hypermetabolism of elastofibroma dorsi on PET-CT AJR Am J Roentgenol 183 35 37 15208104
35. O. Israel N. Yefremov R. Bar-Shalom, et al. 2005 PET/CT detection of unexpected gastrointestinal foci of 18FFDG uptake: incidence, localization patterns, and clinical significance J Nucl Med 46 758 762 15872347